Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Screening for sexually transmitted infections

INTRODUCTION

Sexually transmitted infections (STIs) are a major public health problem in developed and developing countries. Complications of untreated STIs include upper genital tract infections, infertility, cervical cancer, and enhanced transmission and acquisition of the human immunodeficiency virus (HIV).

The approach to STI diagnosis and management is based upon disease or symptom-specific syndromes, including vaginal discharge, urethral discharge, ulcerative genital disease, nonulcerative genital disease, and pelvic pain. However, many patients have asymptomatic disease, which increases the risk of complications and sustained transmission in the community. Unfortunately, routine screening of all patients is cost-prohibitive, particularly in resource-poor countries [1]. Targeted screening of asymptomatic patients in specified risk groups is important and has been shown to be effective.

STI screening, including targeted screening and prevention, will be discussed here. In its 2010 guidelines on the treatment of sexually transmitted infections, the United States Centers for Disease Control and Prevention (CDC) also made recommendations on screening [2]. The recommendations in this topic are largely consistent with those guidelines.

The approaches to patients with specific genitourinary symptoms and signs are discussed elsewhere. (See "Approach to women with symptoms of vaginitis" and "Clinical features and diagnosis of pelvic inflammatory disease" and "Approach to the patient with genital ulcers" and "Acute uncomplicated cystitis and pyelonephritis in women".) The prevention of STIs is discussed elsewhere. (See "Prevention of sexually transmitted infections".)

Information on the clinical presentation, diagnosis, and treatment of specific STIs are reviewed in detail separately. (See related topics). Sexually transmitted infections and HIV infection in adolescents are also discussed separately. (See "Sexually transmitted diseases: Overview of issues specific to adolescents" and "The adolescent with HIV infection".)

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2014. | This topic last updated: Jun 25, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Low N, Broutet N, Adu-Sarkodie Y, et al. Global control of sexually transmitted infections. Lancet 2006; 368:2001.
  2. http://www.cdc.gov/std/treatment/2010/default.htm (Accessed on January 03, 2011).
  3. Torkko KC, Gershman K, Crane LA, et al. Testing for Chlamydia and sexual history taking in adolescent females: results from a statewide survey of Colorado primary care providers. Pediatrics 2000; 106:E32.
  4. Boekeloo BO, Marx ES, Kral AH, et al. Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health 1991; 81:1645.
  5. Ness RB, Smith KJ, Chang CC, et al. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis 2006; 33:137.
  6. Centers for Disease Control and Prevention, Division of STD Prevention. Sexually Transmitted Disease Surveillance 2012, January 2014. http://www.cdc.gov/std/stats12/Surv2012.pdf (Accessed on June 25, 2014).
  7. Bernstein KT, Zenilman J, Olthoff G, et al. Gonorrhea reinfection among sexually transmitted disease clinic attendees in Baltimore, Maryland. Sex Transm Dis 2006; 33:80.
  8. Lofy KH, Hofmann J, Mosure DJ, et al. Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002. Sex Transm Dis 2006; 33:63.
  9. Kerani RP, Handcock MS, Handsfield HH, Holmes KK. Comparative geographic concentrations of 4 sexually transmitted infections. Am J Public Health 2005; 95:324.
  10. Niccolai LM, Ethier KA, Kershaw TS, et al. New sex partner acquisition and sexually transmitted disease risk among adolescent females. J Adolesc Health 2004; 34:216.
  11. Klausner JD, Kent CK, Wong W, et al. The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex Transm Dis 2005; 32:S11.
  12. Kahn RH, Voigt RF, Swint E, Weinstock H. Early syphilis in the United States identified in corrections facilities, 1999-2002. Sex Transm Dis 2004; 31:360.
  13. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145:564.
  14. Hoebe CJ, Rademaker CW, Brouwers EE, et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis 2006; 33:491.
  15. Hobbs MM, van der Pol B, Totten P, et al. From the NIH: proceedings of a workshop on the importance of self-obtained vaginal specimens for detection of sexually transmitted infections. Sex Transm Dis 2008; 35:8.
  16. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55:1.
  17. Campos-Outcalt D, Mickey T, Weisbuch J, Jones R. Integrating routine HIV testing into a public health STD clinic. Public Health Rep 2006; 121:175.
  18. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55:1.
  19. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873.
  20. Gaydos CA, Kent CK, Rietmeijer CA, et al. Prevalence of Neisseria Gonorrhoeae among men screened for Chlamydia Trachomatis in four United States cities, 1999-2003. Sex Transm Dis 2006; 33:314.
  21. US Preventive Services Task Force. Screening for gonorrhea. Agency for Healthcare Research and Quality, Rockville, MD. Revised January 2006. http://www.ahrq.gov/clinic/uspstf/uspsgono.htm (Accessed on June 05, 2006).
  22. Kohl KS, Markowitz LE, Koumans EH. Developments in the screening for Chlamydia trachomatis: a review. Obstet Gynecol Clin North Am 2003; 30:637.
  23. US Preventive Services Task Force. Screening for chlamydial infection: recommendations and rationale. Am J Prev Med 2001; 20:90.
  24. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362.
  25. Seña AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis 2007; 44:13.
  26. McClelland RS, Sangare L, Hassan WM, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 195:698.
  27. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 197:548.
  28. US Preventive Services Task Force. Screening for syphilis. Agency for Healthcare Research and Quality, Rockville, MD. Release date 2004. http://www.ahrq.gov/clinic/uspstf/uspssyph.htm (Accessed on June 05, 2006).
  29. Wong W, Chaw JK, Kent CK, Klausner JD. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis 2005; 32:458.
  30. Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006. MMWR Morb Mortal Wkly Rep 2008; 57:872.
  31. Stanberry L, Cunningham A, Mertz G, et al. New developments in the epidemiology, natural history and management of genital herpes. Antiviral Res 1999; 42:1.
  32. Krone MR, Wald A, Tabet SR, et al. Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261.
  33. US Preventive Services Task Force. Screening for herpes. Agency for Healthcare Research and Quality, Rockville, MD. Release date 2005. http://www.ahrq.gov/clinic/uspstf/uspsherp.htm (Accessed on June 05, 2006).
  34. Kaul R, Nagelkerke NJ, Kimani J, et al. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196:1692.
  35. Kamb ML. Cervical cancer screening of women attending sexually transmitted disease clinics. Clin Infect Dis 1995; 20 Suppl 1:S98.
  36. Kanno MB, Nguyen RH, Lee EM, et al. The prevalence of abnormal cervical cytology in a sexually transmitted diseases clinic. Int J STD AIDS 2005; 16:549.
  37. Casey C, Vellozzi C, Mootrey GT, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55:1.
  38. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1.
  39. Nsuami M, Taylor SN, Sanders LS, Martin DH. Missed opportunities for early detection of chlamydia and gonorrhea in school-based health centers. Sex Transm Dis 2006; 33:703.
  40. Majeroni BA, Ukkadam S. Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician 2007; 76:265.
  41. Gunn RA, O'Brien CJ, Lee MA, Gilchick RA. Gonorrhea screening among men who have sex with men: value of multiple anatomic site testing, San Diego, California, 1997-2003. Sex Transm Dis 2008; 35:845.
  42. Rieg G, Lewis RJ, Miller LG, et al. Asymptomatic sexually transmitted infections in HIV-infected men who have sex with men: prevalence, incidence, predictors, and screening strategies. AIDS Patient Care STDS 2008; 22:947.
  43. Götz HM, van Doornum G, Niesters HG, et al. A cluster of acute hepatitis C virus infection among men who have sex with men--results from contact tracing and public health implications. AIDS 2005; 19:969.
  44. Marrazzo JM, Koutsky LA, Kiviat NB, et al. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health 2001; 91:947.
  45. Dang T, Jaton-Ogay K, Flepp M, et al. High prevalence of anorectal chlamydial infection in HIV-infected men who have sex with men in Switzerland. Clin Infect Dis 2009; 49:1532.
  46. Phipps W, Stanley H, Kohn R, et al. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care STDS 2005; 19:495.
  47. McClelland RS, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 2005; 191:333.
  48. Chesson HW, Heffelfinger JD, Voigt RF, Collins D. Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002. Sex Transm Dis 2005; 32:265.
  49. http://hab.hrsa.gov/deliverhivaidscare/files/hepccoinfectguide2011.pdf (Accessed on July 20, 2012).
  50. Hall CS, Marrazzo JD. Emerging issues in management of sexually transmitted diseases in HIV infection. Curr Infect Dis Rep 2007; 9:518.
  51. Seña AC, Mertz KJ, Thomas D, et al. A survey of sexually transmitted diseases/HIV coinfection testing and reporting practices among health care providers in New Jersey. Sex Transm Dis 2005; 32:406.
  52. van de Laar T, Pybus O, Bruisten S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology 2009; 136:1609.
  53. van der Helm JJ, Prins M, del Amo J, et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011; 25:1083.
  54. Centers for Disease Control and Prevention (CDC). Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011; 60:945.
  55. Taylor LE, Holubar M, Wu K, et al. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis 2011; 52:812.
  56. Linas BP, Wong AY, Schackman BR, et al. Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men. Clin Infect Dis 2012; 55:279.
  57. Hopkins RS, Jajosky RA, Hall PA, et al. Summary of notifiable diseases--United States, 2003. MMWR Morb Mortal Wkly Rep 2005; 52:1.
  58. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352:676.